Disclosure of industry payments to physicians

New England Journal of Medicine

Volumn 359, Issue 6, 2008, Pages 559-561

  Steinbrook, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MANUFACTURE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; MEDICAL FEE; MEDICAL INSTRUMENTATION; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 49249125362     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0805309     Document Type: Article

References (5)

1. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med 2007;356:1742-50.
2. Campbell EG, Weissman JS, Ehringhaus S, et al. Institutional academic-industry relationships. JAMA 2007;298:1779-86.
3. Harris G, Carey B. Researchers fail to reveal full drug pay. New York Times. June 8, 2008:A1.
4. Ross JS, Lackner JE, Lurie P, Gross CP, Wolfe S, Krumholz HM. Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA 2007;297:1216-23.
5. Industry funding of medical education: report of an AAMC task force. Washington, DC: American Association of Medical Colleges, 2008. (Accessed July 18, 2008 at http://www.aamc.org/industryfunding.)